Literature DB >> 22732952

Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island.

Catherine Marimoutou1, Elodie Vivier, Manuela Oliver, Jean-Paul Boutin, Fabrice Simon.   

Abstract

We compared the morbidity and quality of life of military policemen ("gendarmes") infected with chikungunya virus (CHIKV+) 30 months after contamination. We categorized the subjects in 3 groups: healed patients (n = 48), non-healed patients (n = 37, 44% of CHIKV+), and uninfected subjects (CHIKV-, n = 297). Data were self-recorded in this retrospective cohort study; they included sociodemographic information, clinical symptoms, and the Medical Outcome Study 36-item short-form health survey (MOS-SF36) quality of life questionnaire. The study population was mostly men (92%), with a median age of 42.8 years, regardless of CHIKV status. The main complaints were rheumatic symptoms (pain, stiffness, and swelling), reported 5 times more often by non-healed CHIKV+ subjects and 2-3 times more often by healed CHIKV+ subjects than by CHIKV- subjects, and fatigue. The CHIKV+ patients reported more use of health care services. Thirty months after infection, all rheumatic symptoms were more frequent and intense among CHIKV+ than among CHIKV- subjects, with a gradient of severity between healed and non-healed CHIKV+ subjects. Non-healed CHIKV+ subjects reported subsequent limitation in their activities. All dimensions of MOS-SF36 as well as physical and mental component summaries were impaired in CHIKV+ compared to CHIKV- subjects, with a decreasing gradient of impairment from non-healed to healed CHIKV+ subjects, then to CHIKV- subjects. These observations confirm the long-term impact of CHIKV infection on both physical and mental health. Questions persist regarding the duration of this impairment and the possibility of a return to "before CHIKV" health status for infected patients.

Entities:  

Mesh:

Year:  2012        PMID: 22732952     DOI: 10.1097/MD.0b013e318260b604

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  26 in total

1.  Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study.

Authors:  Brieg Couzigou; Anne Criquet-Hayot; Emilie Javelle; Sandrine Tignac; Edith Mota; François Rigaud; Alizé Alain; Odile Troisgros; Sandrine Pierre-Francois; Sylvie Abel; Rishika Banydeen; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

Review 2.  Chikungunya fever: a threat to global public health.

Authors:  Raíza Nara Cunha Moizéis; Thales Allyrio Araújo de Medeiros Fernandes; Paulo Marcos da Matta Guedes; Hannaly Wana Bezerra Pereira; Daniel Carlos Ferreira Lanza; Judson Welber Veríssimo de Azevedo; Josélio Maria de Araújo Galvão; José Veríssimo Fernandes
Journal:  Pathog Glob Health       Date:  2018-05-28       Impact factor: 2.894

3.  Identification and Characterization of Sindbis Virus RNA-Host Protein Interactions.

Authors:  Autumn T LaPointe; Natasha N Gebhart; Megan E Meller; Richard W Hardy; Kevin J Sokoloski
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial Fluid.

Authors:  Aileen Y Chang; Karen A O Martins; Liliana Encinales; St Patrick Reid; Marlon Acuña; Carlos Encinales; Christian B Matranga; Nelly Pacheco; Carlos Cure; Bhavarth Shukla; Teofilo Ruiz Arteta; Richard Amdur; Lisa H Cazares; Melissa Gregory; Michael D Ward; Alexandra Porras; Alejandro Rico Mendoza; Lian Dong; Tara Kenny; Ernie Brueggemann; Lydia G Downey; Priyanka Kamalapathy; Paola Lichtenberger; Orlando Falls; Gary L Simon; Jeffrey M Bethony; Gary S Firestein
Journal:  Arthritis Rheumatol       Date:  2018-03-07       Impact factor: 10.995

5.  Machine learning and deep learning techniques to support clinical diagnosis of arboviral diseases: A systematic review.

Authors:  Sebastião Rogério da Silva Neto; Thomás Tabosa Oliveira; Igor Vitor Teixeira; Samuel Benjamin Aguiar de Oliveira; Vanderson Souza Sampaio; Theo Lynn; Patricia Takako Endo
Journal:  PLoS Negl Trop Dis       Date:  2022-01-13

Review 6.  Unexplained post-acute infection syndromes.

Authors:  Jan Choutka; Viraj Jansari; Mady Hornig; Akiko Iwasaki
Journal:  Nat Med       Date:  2022-05-18       Impact factor: 87.241

7.  Diagnostic challenges in chikungunya infection: Report of an atypical presentation.

Authors:  J Craig; M Klowak; A K Boggild
Journal:  Can Commun Dis Rep       Date:  2015-01-08

8.  Psychiatric Morbidity in Patients with Chikungunya Fever: First Report from India.

Authors:  M S Bhatia; Priyanka Gautam; Anurag Jhanjee
Journal:  J Clin Diagn Res       Date:  2015-10-01

9.  Phenotypic and Kinetic Changes of Myeloid Lineage Cells in Innate Response to Chikungunya Infection in Cynomolgus Macaques.

Authors:  Brandon J Beddingfield; Chie Sugimoto; Eryu Wang; Scott C Weaver; Kasi E Russell-Lodrigue; Stephanie Z Killeen; Marcelo J Kuroda; Chad J Roy
Journal:  Viral Immunol       Date:  2022-03-25       Impact factor: 2.175

10.  Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012.

Authors:  Emilie Javelle; Anne Ribera; Isabelle Degasne; Bernard-Alex Gaüzère; Catherine Marimoutou; Fabrice Simon
Journal:  PLoS Negl Trop Dis       Date:  2015-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.